Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Fabrazzo

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|November 25, 2021
A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativaMichele Fabrazzo, Salvatore Cipolla, Simona Signoriello, et al.
Biological Psychiatry|April 12, 2005
Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosaPalmiero Monteleone, Vassilis Martiadis, Antonello E Rigamonti, et al.
Rivista Di Psichiatria|July 1, 2016
[Drug safety warnings in psychiatry: adverse drug reactions' signaling from 2002 to 2014]Vincenzo Prisco, Teresa Iannaccone, Adriano Tusciano, et al.
Frontiers in Psychiatry|April 21, 2022
Social Cognition Individualized Activities Lab for Social Cognition Training and Narrative Enhancement in Patients With Schizophrenia: A Randomized Controlled Study to Assess Efficacy and Generalization to Real-Life Functioning (Prot. n°: NCT05130853)Davide Palumbo, Edoardo Caporusso, Giuseppe Piegari, et al.
Psychiatry Research|January 7, 2014
Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposurePalmiero Monteleone, Carmela Di Filippo, Michele Fabrazzo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 5, 2002
Is the time course of clozapine response correlated to the time course of clozapine plasma levels? A one-year prospective study in drug-resistant patients with schizophreniaMichele Fabrazzo, Silvestro La Pia, Palmiero Monteleone, et al.
Psychiatry Research|March 26, 2021
Duration of untreated illness predicts 3-year outcome in patients with obsessive-compulsive disorder: A real-world, naturalistic, follow-up studyFrancesco Perris, Gaia Sampogna, Vincenzo Giallonardo, et al.
Medicina (Kaunas, Lithuania)|November 27, 2021
Delirium and Cognitive Impairment as Predisposing Factors of COVID-19 Infection in Neuropsychiatric Patients: A Narrative ReviewMichele Fabrazzo, Antonio Russo, Alessio Camerlengo, et al.
Neuropsychobiology|September 5, 2015
Olanzapine Is Faster than Haloperidol in Inducing Metabolic Abnormalities in Schizophrenic and Bipolar PatientsMichele Fabrazzo, Palmiero Monteleone, Vincenzo Prisco, et al.
Journal of Clinical Medicine|January 11, 2022
Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) StudyGiulia M Giordano, Pasquale Pezzella, Mario Quarantelli, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
European Psychiatry : the Journal of the Association of European Psychiatrists|November 25, 2021
A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativaMichele Fabrazzo, Salvatore Cipolla, Simona Signoriello, et al.
Biological Psychiatry|April 12, 2005
Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosaPalmiero Monteleone, Vassilis Martiadis, Antonello E Rigamonti, et al.
Rivista Di Psichiatria|July 1, 2016
[Drug safety warnings in psychiatry: adverse drug reactions' signaling from 2002 to 2014]Vincenzo Prisco, Teresa Iannaccone, Adriano Tusciano, et al.
Frontiers in Psychiatry|April 21, 2022
Social Cognition Individualized Activities Lab for Social Cognition Training and Narrative Enhancement in Patients With Schizophrenia: A Randomized Controlled Study to Assess Efficacy and Generalization to Real-Life Functioning (Prot. n°: NCT05130853)Davide Palumbo, Edoardo Caporusso, Giuseppe Piegari, et al.
Psychiatry Research|January 7, 2014
Flattened cortisol awakening response in chronic patients with schizophrenia onset after cannabis exposurePalmiero Monteleone, Carmela Di Filippo, Michele Fabrazzo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 5, 2002
Is the time course of clozapine response correlated to the time course of clozapine plasma levels? A one-year prospective study in drug-resistant patients with schizophreniaMichele Fabrazzo, Silvestro La Pia, Palmiero Monteleone, et al.
Psychiatry Research|March 26, 2021
Duration of untreated illness predicts 3-year outcome in patients with obsessive-compulsive disorder: A real-world, naturalistic, follow-up studyFrancesco Perris, Gaia Sampogna, Vincenzo Giallonardo, et al.
Medicina (Kaunas, Lithuania)|November 27, 2021
Delirium and Cognitive Impairment as Predisposing Factors of COVID-19 Infection in Neuropsychiatric Patients: A Narrative ReviewMichele Fabrazzo, Antonio Russo, Alessio Camerlengo, et al.
Neuropsychobiology|September 5, 2015
Olanzapine Is Faster than Haloperidol in Inducing Metabolic Abnormalities in Schizophrenic and Bipolar PatientsMichele Fabrazzo, Palmiero Monteleone, Vincenzo Prisco, et al.
Journal of Clinical Medicine|January 11, 2022
Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) StudyGiulia M Giordano, Pasquale Pezzella, Mario Quarantelli, et al.
Pageof 5